MELANI FRANCESCO,GIULIANI SANDRO,MAGGI CARLO ALBERTO
申请号:
NZ60341411
公开号:
NZ603414A
申请日:
2011.05.09
申请国别(地区):
NZ
年份:
2014
代理人:
摘要:
ABSTRACT - 603414 The disclosure relates to a combination of active principles, i.e. of a xanthine oxidase inhibitor: febuxostat with one or more angiotensin II receptor antagonists belonging to the class of sartans selected from the group comprising: olmesartan medoximil, candesartan, eprosartan, irbesartan, losartan, telmisartan, valsartan or pharmaceutically acceptable salts thereof, for use in a human or veterinary therapeutic treatment, and methods for the preparation thereof. These compositions are suitable and effective in the therapeutic treatment of hypertension associated to hyperuricemia or to other disorders in the clinical context of the metabolic syndrome.